Latest news
The FDA Gives Accelerated Approval to Melanoma Treatment - PharmTech.comPharmTech.com · Fri, 07 Aug 2026 14:55:43 GMTAfter 2 CRLs, FDA Approves Vusolimogene Oderparepvec With Nivolumab for Advanced Melanoma - Pharmacy TimesPharmacy Times · Thu, 06 Aug 2026 20:58:22 GMTFDA Votes 10 to 3 in Favor of Replimune's Rp1 Efficacy Data | PharmExec - Pharmaceutical ExecutivePharmaceutical Executive · Fri, 31 Jul 2026 07:00:00 GMT